Skip to main content
Top
Published in: Trials 1/2019

Open Access 01-12-2019 | Cough | Research

Application via mechanical dropper alleviates sufentanil-induced cough: a prospective, randomized, single-blinded trial

Authors: Minqiang Liu, Zhichao Li, Song Wang, Yong Liu, Xiangpeng Zhong, Renliang He, Fengxian Li

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

It was reported that prolonging the injection time or diluting administration can reduce the incidence of opioid-induced cough. However, the incidence of sufentanil-induced cough (SIC) via a standardized infusion rate is unclear. A mechanical dropper is an infusion filtering device commonly used for intravenous degassing; it can also be used to administer special drugs due to its temporary storage and dilution effect. This study assesses the effectiveness of administration via mechanical dropper on SIC.

Methods

Two hundred patients undergoing general anesthesia were enrolled. Patients received sufentanil at a strength of 0.3 μg·kg− 1 either via T-connector (group C) or by mechanical dropper (group M) at 1 ml·s− 1. Cough severity was graded as none (0), mild (1–2), moderate (3–5), or severe (> 5), and the incidence of SIC was evaluated for 5 min after the start of sufentanil injection. Other adverse reactions such as hypotension, hypertension, bradycardia, tachycardia, hypoxemia, vomiting, and aspiration during the induction period of general anesthesia were also observed. The primary outcome was the incidence of SIC. The secondary outcomes were the severity of SIC and other adverse reactions.

Results

The incidence of SIC in group M was significantly lower than that in group C (2% versus 21%, P = 0.000), and the prevalence of moderately severe coughing was also statistically different (none in group M versus 11% in group C, P = 0.001). However, there were no statistical differences in the incidence of other adverse reactions between two groups (P > 0.05).

Conclusion

Sufentanil application via mechanical dropper can significantly alleviate the occurrence of SIC during the induction phase of total intravenous general anesthesia. This method is simple, safe, and reliable, and has wide prospective application for clinical use.

Trial registration

Chinese Clinical Trial Register, ChiCTR-IOR-17011561. Registered on 3 June 2017.
Literature
3.
go back to reference Nguyen TT, Higashi T, Kambayashi Y, Anyenda EO, Michigami Y, Hara J, et al. A longitudinal study of association between heavy metals and itchy eyes, coughing in chronic cough patients: related with non-immunoglobulin E mediated mechanism. Int J Environ Res Public Health. 2016;13(1):110. https://doi.org/10.3390/ijerph13010110. Nguyen TT, Higashi T, Kambayashi Y, Anyenda EO, Michigami Y, Hara J, et al. A longitudinal study of association between heavy metals and itchy eyes, coughing in chronic cough patients: related with non-immunoglobulin E mediated mechanism. Int J Environ Res Public Health. 2016;13(1):110. https://​doi.​org/​10.​3390/​ijerph13010110.
6.
go back to reference Zhang K, Li M, Peng XC, Wang LS, Dong AP, Shen SW, et al. The protective effects of sufentanil pretreatment on rat brains under the state of cardiopulmonary bypass. Iran J Pharm Res. 2015;14(2):559–66 PMID: 25901164 PMCID: PMC4403073.PubMedPubMedCentral Zhang K, Li M, Peng XC, Wang LS, Dong AP, Shen SW, et al. The protective effects of sufentanil pretreatment on rat brains under the state of cardiopulmonary bypass. Iran J Pharm Res. 2015;14(2):559–66 PMID: 25901164 PMCID: PMC4403073.PubMedPubMedCentral
10.
go back to reference An LJ, Gui B, Su Z, Zhang Y, Liu HL. Magnesium sulfate inhibits sufentanil-induced cough during anesthetic induction. Int J Clin Exp Med. 2015;8(8):13864–8 PMCID: PMC4613024.PubMedPubMedCentral An LJ, Gui B, Su Z, Zhang Y, Liu HL. Magnesium sulfate inhibits sufentanil-induced cough during anesthetic induction. Int J Clin Exp Med. 2015;8(8):13864–8 PMCID: PMC4613024.PubMedPubMedCentral
22.
go back to reference Dewdney A, Cunningham D, Barbachano Y, Chau I. Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection. Br J Cancer. 2012;106(11):1718–21. https://doi.org/10.1038/bjc.2012.152.CrossRefPubMedPubMedCentral Dewdney A, Cunningham D, Barbachano Y, Chau I. Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection. Br J Cancer. 2012;106(11):1718–21. https://​doi.​org/​10.​1038/​bjc.​2012.​152.CrossRefPubMedPubMedCentral
Metadata
Title
Application via mechanical dropper alleviates sufentanil-induced cough: a prospective, randomized, single-blinded trial
Authors
Minqiang Liu
Zhichao Li
Song Wang
Yong Liu
Xiangpeng Zhong
Renliang He
Fengxian Li
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3274-y

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue